(R)-tert-Butyl (1-(pyridin-4-ylmethyl)pyrrolidin-3-yl)carbamate

Catalog No. :
ACSMWO201
CAS No. :
1286207-55-3
Molecular Formula :
C15H23N3O2
Molecular Weight :
277.37

IUPAC Name:tert-butyl (R)-(1-(pyridin-4-ylmethyl)pyrrolidin-3-yl)carbamate

(R)-tert-Butyl (1-(pyridin-4-ylmethyl)pyrrolidin-3-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$288.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-tert-Butyl (1-(pyridin-4-ylmethyl)pyrrolidin-3-yl)carbamate
IUPAC Nametert-butyl (R)-(1-(pyridin-4-ylmethyl)pyrrolidin-3-yl)carbamate
MDL No.MFCD18378066
Molecular FormulaC15H23N3O2
Molecular Weight277.37
SMILESO=C(OC(C)(C)C)N[C@H]1CN(CC2=CC=NC=C2)CC1
InChI KeyBLXINULUCAENHC-CYBMUJFWSA-N
Synonym(R)-tert-Butyl 1-(pyridin-4-ylmethyl)pyrrolidin-3-ylcarbamate;Carbamic acid, N-[(3R)-1-(4-pyridinylmethyl)-3-pyrrolidinyl]-, 1,1-dimethylethyl ester
CAS No.1286207-55-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACSMWO201 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBZXE159 route compound structure diagram
    ACBZXE1591416450-63-9 In Stock
  2. Plus
  3. ACBXKY017 route compound structure diagram
    ACBXKY017872-85-5 In Stock
  4. Then
  5. ACSMWO201 route product structure diagram
    ACSMWO2011286207-55-3
Inquiry

2. ACSMWO201 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIWFG521 route compound structure diagram
    ACIWFG52173870-24-3 In Stock
  2. Plus
  3. ACBZXE159 route compound structure diagram
    ACBZXE1591416450-63-9 In Stock
  4. Then
  5. ACSMWO201 route product structure diagram
    ACSMWO2011286207-55-3
Inquiry

Comments (0)